We have measured the self-diffusion coefficients of a
series of solute probes, including
ethylene glycol and its oligomers and polymers in aqueous solutions and
gels of poly(vinyl alcohol) (PVA)
using the pulsed-gradient spin−echo NMR techniques. In an effort
to link the diffusion properties of
small and large molecules in polymer systems, we have selected this
group of diffusant probes with various
molecular weights, ranging from 62 to 4000. The self-diffusion
coefficients of the solute probes decrease
with increasing PVA concentrations (from 0 to 0.38 g/mL) and with
increasing molecular size of the probes.
The temperature dependence of the self-diffusion coefficients has
also been studied for ethylene glycol
and poly(ethylene glycol)s of molecular weights 600 and 2000.
Energy barriers of 30.0, 36.5, and 39.0
kJ/mol have been calculated respectively for the probes, in the
temperature range 23−53 °C. The
experimental data are used to fit a new physical model of diffusion
(Petit et
al.
Macromolecules,
1996,
29, 6031), which is shown to be successful in describing the
effects of polymer concentration, temperature,
and molecular size of the diffusants on the self-diffusion coefficients
of small and large molecular probes
in the polymer system.
To test the effect of the matrix polymer on diffusion, we have measured the self-diffusion
coefficients of water and poly(ethylene glycol) of a molecular weight of 600 (PEG-600) in aqueous systems
of selected polymers using the pulsed-gradient spin-echo NMR technique. The polymers used in this study
include poly(vinyl alcohol) (PVA), hydroxypropyl methyl cellulose (HPMC), poly(N,N-diethylacrylamide)
(PNNDEA), and poly(N-isopropylacrylamide) (PNIPA). The polymer concentrations varied from 0 to 0.38
g/mL. The effect of the polymer network on the self-diffusion coefficients of the solvent (water) and a
solute (PEG-600) was investigated by analyzing the diffusion data with the use of the free volume model
of Yasuda et al. [Yasuda, H.; Lamaze, C. E.; Ikenberry, L. D. Makromol. Chem.
1968, 118, 19], the diffusion
model proposed by Phillies [Phillies, G. D. J. Macromolecules
1986, 19, 2367], and the model of Petit et
al. [Petit, J.-M.; Roux, B.; Zhu, X. X.; Macdonald, P. M. Macromolecules
1996, 29, 6031]. The results
obtained with PVA, HPMC, PNNDEA, and PNIPA are used to evaluate the applicability of these models
in polymer−water−solute ternary systems. The physical significance of the parameters used in the models
is discussed.
The conformations of three angiotensin II (AII) peptide antagonists ([Sar1]-AII(1-7)-NH(2), [Sar1,Val5,Ala8]-AII and the AII antipeptide, [Glu1,Gly2,Val5,Val8]-AII) were assessed in a lipid medium. A common backbone turn was identified through modeling and spectroscopic studies. The His6 residue acted as a pivoting point beyond which each peptide adopted two distinct conformations. One principle conformer resembled that previously determined for AII while the other was designated as an AII antagonist like conformer. A computational overlay between the nonpeptide antagonist, Losartan, and both the AII and the AII like conformation of [Sar1,Val5,Ala8]-AII revealed common pharmacophoric points with RMS deviations between 1 and 1.5 A. Both the AII conformer and the AII antagonist like conformer of [Sar1,Val5,Ala8]-AII were docked into a model of the AT(1) receptor. Receptor residue Phe289 and Asp281 provided good contact points for both peptides. Some differences were also noted. The terminal carboxyl of AII contacted Lys199 of the receptor while that of [Sar1,Val5,Ala8]-AII bridged Arg23 at the top of helix 1. The Asp1 side chain of AII interacted with His183 of the receptor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.